It’s hard to find economic success stories in a pandemic that aren’t somehow a result of the crisis, but there’s one standing on Amgen Rhode Island’s West Greenwich campus. A $200 million biomanufacturing plant – the first of its modular design in the United States – was finished this year. When it becomes fully operational
Already a Subscriber? Log in
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber
- Critical RI business news and analysis updated daily.
- 1 year of print (26 issues).
- Unlimited access to all subscriber only content on our website, on any device.
- Free email alerts.
- Annual Book of Lists Print Edition.
- All special issues produced during subscription term.
Click Here to purchase a paywall bypass link for this article
PBN Branded Content
Diversity matters at Amgen
We believe our differences lead to better science and better business outcomes, enabling us to…
Learn More
